PortfoliosLab logo

CASI Pharmaceuticals, Inc. (CASI)

Equity · Currency in USD · Last updated Jun 28, 2022

Company Info

ISINUS14757U1097
CUSIP14757U109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.03
Year Range$2.94 - $16.80
EMA (50)$4.18
EMA (200)$7.95
Average Volume$74.40K
Market Capitalization$40.27M

CASIShare Price Chart


Chart placeholderClick Calculate to get results

CASIPerformance

The chart shows the growth of $10,000 invested in CASI Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $332 for a total return of roughly -96.68%. All prices are adjusted for splits and dividends.


CASI (CASI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CASIReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-18.11%-6.21%
YTD-62.12%-18.17%
6M-65.31%-17.47%
1Y-81.30%-8.89%
5Y-21.16%10.04%
10Y-16.22%11.26%

CASIMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

CASISharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current CASI Pharmaceuticals, Inc. Sharpe ratio is -1.01. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


CASI (CASI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CASIDividend History


CASI Pharmaceuticals, Inc. doesn't pay dividends

CASIDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


CASI (CASI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

CASIWorst Drawdowns

The table below shows the maximum drawdowns of the CASI Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the CASI Pharmaceuticals, Inc. is 97.53%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.53%Jan 11, 20103130Jun 16, 2022

CASIVolatility Chart

Current CASI Pharmaceuticals, Inc. volatility is 75.75%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


CASI (CASI Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Portfolios with CASI Pharmaceuticals, Inc.


Loading data...